- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT05123495
Device Briefing Tool and Surgical Safety Checklist Implementation
Safe Introduction of a New Surgical Device With the Device Briefing Tool and Surgical Safety Checklist in Singapore
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Design of Quality Improvement Initiative Using a prospective observational implementation design, surgical teams will be assigned to 1 of 2 groups. Group I will receive the complete intervention, which includes implementation of the DBT from the start, and then the DBT and SSC package.
Group II does not receive the DBT alone; these teams continue with their usual care, and then receive the DBT and SSC package.
Device-related interruptions, non-technical skills of surgical teams, and Culture of Safety Survey will be measured pre- and post-implementation of the SSC and DBT interventions, with specific timing depended on group allocation. OR teams at each hospital will be observed longitudinally to assess the effects of the DBT and SSC interventions.
Target Population for the Quality Improvement Initiative Participants will be members of the OR team at each participating hospital. These members include practicing surgeons, anesthesiologists, OR nurses, and OR staff. Hospitals will be participating institutions of SingHealth and NUHS hospital clusters. J&J device sales representatives ("reps") will serve as key trainers during the multidisciplinary trainings to use the DBT during an operation. A separate implementation team will be trained by Ariadne Labs to execute the SSC at each eligible hospital. Hospital leadership will be key stakeholders to engage at each hospital in order to implement the DBT, team training, and SSC program.
Interventions Device Briefing Tool: a 4-item mini-checklist focused on raising OR team awareness to the nuances of a new surgical device.
Trained J&J sales reps will be responsible for training OR teams to use the DBT with the new surgical device. Ariadne Labs will provide initial training to the J&J reps and be available for ongoing training support.
Safe Surgery Checklist: Developed with the World Health Organization, the SSC is a 19-item checklist consisting of verbal confirmation by surgical teams of the completion of the basic steps for ensuring the safe delivery of anesthesia, prophylaxis against infection, effective teamwork, among other essential practices in surgery. As described elsewhere in greater detail, it is used at 3 critical junctures of care: before anesthesia is administered, immediately before incision is made, and before the patient is taken out of the operating room. A successful implementation of the SSC is a labor-intensive iterative process that includes 4 phases: prepare, own, expand, and improve.
Ariadne Labs will provide the specialists needed to implement the SSC and to support local hospitals' implementation teams. Please refer to the SSC Implementation Guide for process details in the Supplemental Materials.
Outcomes to Study Device-related interruptions: Any interruption in the surgical team's workflow as the result of the use of the study device.
Non-technical skills: Evaluation of OR team performance for non-technical skills (situation awareness, decision-making, cooperation and teamwork, and leadership), using the NOTECHS assessment, a validated rating system for intraoperative OR team behavior.
Perception of safety, i.e. "safety culture": The perception of safety among members of the OR team will be measured using the Culture of Safety Survey.
Site readiness assessment: We will evaluate the readiness capacity of institutions to implement the DBT/SSC intervention using the Readiness Assessment Tool.
Goal: Determine if the pre-intervention Readiness Assessment Tool is predictive (R2 > 0.7) of implementation success as gauged by the post-intervention Implementation Survey.
Feasibility of scale: The scale of this project will be measured by the number of personnel trained, the number of hospitals at which the DBT, team training, and SSC intervention is implemented, and adherence rates to the intervention.
Studientyp
Einschreibung (Tatsächlich)
Kontakte und Standorte
Studienorte
-
-
-
Singapore, Singapur
- Singapore General Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Kind
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- Surgical teams in SingHealth hospitals
Exclusion Criteria:
- Refusal by any team member to participate
Note - there are NO specific age criteria, since the unit of analysis is the surgical team rather than the patient. It is highly unlikely that any surgical team member would be less than 18 years of age or greater than 89 years of age, but there are no explicit age-based exclusions.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
Device Briefing Tool Implementation
Surgical departments which receive training on use of the Device Briefing Tool
|
A 4-item supplement to the WHO Surgical Safety Checklist designed to improve teamwork and communication around new/complex surgical devices
Reimplementation of the WHO Surgical Safety Checklist to improve adherence and utility of the checklist
|
|
Comparator
Surgical departments that do not receive training on use of the Device Briefing Tool
|
Reimplementation of the WHO Surgical Safety Checklist to improve adherence and utility of the checklist
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Oxford NOTECHS scale
Zeitfenster: Change in NOTECHS scores will be assessed from baseline to immediately after DBT implementation and 2-months after SSC implementation
|
Measure of non-technical skills of surgical teams assessed by neutral observers.
Scored 12-48 with higher scores indicating better non-technical skills.
|
Change in NOTECHS scores will be assessed from baseline to immediately after DBT implementation and 2-months after SSC implementation
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Device-related interruptions (DRIs)
Zeitfenster: Change in DRIs will be assessed from baseline to immediately after DBT implementation and 2-months after SSC implementation
|
The number of times surgical teams must cease activity due to a problem with a surgical device
|
Change in DRIs will be assessed from baseline to immediately after DBT implementation and 2-months after SSC implementation
|
|
Culture of safety
Zeitfenster: Change in safety culture from baseline will be assessed 2-months post-SSC
|
Safety culture, as measured by division-wide Hospital Survey on Patient Safety Culture (HSOPS) survey.
HSOPS is scored from 0 to 100% with higher scores indicating better safety culture.
|
Change in safety culture from baseline will be assessed 2-months post-SSC
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Joaquim Havens, MD, Ariadne Labs
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- IRB19-0389
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .